These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7841575

  • 1. Intralipid in prophylaxis of amphotericin B nephrotoxicity.
    Vita E, Schroeder DJ.
    Ann Pharmacother; 1994 Oct; 28(10):1182-3. PubMed ID: 7841575
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of Intralipid emulsions of amphotericin B.
    Herbrecht R, Letscher V.
    J Antimicrob Chemother; 1997 Jul; 40(1):137-9. PubMed ID: 9249219
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.
    Hasibi M, Jafari S, Manshadi SA, Asadollahi M, Salehi M, Zarch VV, Kouhi A.
    Ear Nose Throat J; 2017 Feb; 96(2):E18-E22. PubMed ID: 28231371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [Abstract] [Full Text] [Related]

  • 8. Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
    Branch RA, Jackson EK, Jacqz E, Stein R, Ray WA, Ohnhaus EE, Meusers P, Heidemann H.
    Klin Wochenschr; 1987 Jun 01; 65(11):500-6. PubMed ID: 3475498
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Response to "is liposomal amphotericin B really safety in neonates?".
    Manzoni P, Rizzollo S, Farina D.
    Early Hum Dev; 2013 Jan 01; 89(1):37. PubMed ID: 22831635
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function.
    Burges JL, Birchall R.
    Am J Med; 1972 Jul 01; 53(1):77-84. PubMed ID: 5037291
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Amphotericin B: a second look.
    Medoff G, Kobayashi GS.
    Compr Ther; 1977 Jul 01; 3(7):20-4. PubMed ID: 880788
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May 01; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 19. Sodium chloride treatment of amphotericin B nephrotoxicity. Standard of care?
    Anderson CM.
    West J Med; 1995 Apr 01; 162(4):313-7. PubMed ID: 7747495
    [Abstract] [Full Text] [Related]

  • 20. Clinical correlations during amphotericin B therapy.
    Goodpasture HC, Voth DW, Romig DA, Cheng D, Wenglin BD, Liu C.
    J Kans Med Soc; 1972 Nov 01; 78(11):486-90. PubMed ID: 5078570
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.